Transform Your Cell Therapy CDMO From Service Provider To Partner

By Dr. David Smith, VP of Development, and Dr. Chathuranga De Silva, Sr. Director of Business Development, BioCentriq

If you are a preclinical or early-stage biotechnology company with an eye towards clinical proof of concept, using a CDMO for your manufacturing makes sense. In a previous article, we identified the top 10 intangibles a CDMO must offer to help you select the right CDMO — and know how to look out for tell-tale signs to run the other way. But, say you found that CDMO, or maybe you even have two or three CDMO candidates to choose from (which is the best-case scenario).

In this article, we'll discuss things that a cell therapy CDMO will do to demonstrate that not only are they a strong and capable CDMO but also a true partner in what will be the most important two to three years of your company's journey to success.